![](/img/cover-not-exists.png)
Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
Sullivan, Patrick W, Li, Qianyi, Bilir, S. Pinar, Dang, Joseph, Kavati, Abhishek, Yang, Ming, Rajput, YaminaLanguage:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2019.1660539
Date:
September, 2019
File:
PDF, 890 KB
english, 2019